AVENTIS BEHRING L.L.C.

ABS

Biopharmaceutical preparations for human use containing plasma-derived proteins and recombinant, transgenic, or other synthetic equivalents therefore for use in the medical treatment of hemophilia and immune deficiency diseases as well as those in critical care situations such as burns and shock where restoration of blood volume is key and also for the treatment of healing wounds;

BIOCLATE

pharmaceutical preparation for the treatment of blood disorders;

FOR A BETTER LIFE

EDUCATIONAL PUBLICATIONS, NAMELY, PAMPHLETS, CORPORATE BROCHURES, FOLDERS, BOOKS, BOOKLETS, JOURNAL ARTICLES, POINT-OF-SALE PIECES, BINDERS AND INTERNET SITES DIRECTED TO CONSUMERS AS TO THE TREATMENT OF DISEASES, NAMELY, HEMOPHILIA AND OTHER BLOOD CLOTTING FACTOR DISEASES, IMMUNE SYSTEM DISORDERS, AND CONGENITAL EMPHYSEMA;

LASTIVA

Pharmaceutical preparations used to treat deficiencies of Alpha One proteinase inhibitors;

ZEMIRA

Pharmaceutical preparations used to treat deficiencies of Alpha One proteinase inhibitors;